Animal Models in Cancer Drug Discovery

Erscheinungsjahr 2019
ISBN: 978-0-12-814704-7
Verlag: William Andrew Publishing

Buch, Englisch, 470 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 1070 g

Animal Models in Cancer Drug Discovery brings forward the most cutting-edge developments in tumor model systems for translational cancer research. The reader can find under this one volume virtually all types of existing and emerging tumor models in use by the research community. This book provides a deeper insight on how these newer models could de-risk modern drug discovery. Areas covered include up to date information on latest organoid derived models and newer genetic models. Additionally, the book discusses humanized animal tumor models for cancer immunotherapy and how they leverage personalized therapies. The chapter on larger animal, canine models and their use in and their use in pre-investigational new drug (pre-IND) development makes the volume unique. Unlike before, the incorporation of several simplified protocols, breeding methodologies, handling and assessment procedures to study drug intervention makes this book a must read.

Animal Models in Cancer Drug Discovery is a valuable resource for basic and translational cancer researchers, drug discovery researchers, contract research organizations, and knowledge seekers at all levels in the biomedical field.

Zielgruppe

<p>basic and translational cancer researchers, animal model researchers, drug discovery researchers</p>

Autoren/Hrsg.

Azmi, Asfar

Mohammad, Ramzi M.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Biomedizin, Medizinische Forschung, Klinische Studien
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

1. Cancer Cachexia models2. Ovarian Cancer models3. Role of animal research in human malignancies4. Imaging tools to enhance animal tumor models for cancer research and drug discovery5. Genetic tumor models of pancreatic cancer6. Obesity models of cancer7. Primary Brain Tumor models8. Systemic model brain penetrance analysis9. A guide to tumor model assessment methodologies in cancer drug discovery10. Mouse Models of Pancreatic Cancer: An Ever-emerging Arm of Cancer Drug Discovery11. Murine Models of Gastrointestinal Cancers in Drug Research and Development12. Pre-clinical Animal Tumor Models to Study Prevention of Colon Cancer Recurrence by Curcumin13. Role of 3D tissue engineering models for human cancer and drug development14. Drug Development Using Pancreatic and Lung Organoid Models 15. Leveraging Dogs with Spontaneous Cancer to Advance Drug Development16. PET imaging in Tumor Models17. Melanoma Animal Tumor Models18. Animal Mouse Models of Acute Myeloid Leukemia

Über Autor(innen)

Azmi, Asfar
Asfar Azmi, PhD, is an Assistant Professor at the Department of Oncology, Wayne State University. He has more than a decade of research experience in the area of cancer biology and drug discovery. Dr. Azmi's lab has made significant pre-clinical discoveries in advanced animal tumor models that helped the clinical development of new cancer drugs. Dr. Azmi has considerable experience in the area of early phase clinical research. Several agents developed by his team have gone into Phase II clinical studies. He has published more than 100 cancer research articles and has edited three additional books, among which there are the Elsevier publications Molecular Diagnostics and Treatment of Pancreatic Cancer as well as Conquering Ras. He is the recipient of numerous young investigator awards from premier scientific bodies. The National Institute of Health and pharmaceutical industry have continuously funded his lab.

Mohammad, Ramzi M.
Ramzi M. Mohammad, PhD, is a Professor at the Department of Oncology and Director of GI Research for the Karmanos Cancer Institute, Wayne State University, USA. Dr. Mohammad has more than 25 years of cancer research experience, including extensive experience in animal models. He has established several tumor models of pancreatic cancers and Non-Hodgkin's lymphoma. He was among the first to establish pancreatic orthotopic models. The cell lines and tumors models developed by Dr. Mohammad are in extensive use worldwide for studying new anticancer agents.